Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125455392 | 12545539 | 2 | F | 20160629 | 20160708 | 20160711 | 20160718 | EXP | TW-JNJFOC-20160626931 | JANSSEN | 33.37 | YR | A | M | Y | 55.00000 | KG | 20160718 | OT | TW | TW |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125455392 | 12545539 | 1 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | N | UNKNOWN | 0 | 45 | MG | SOLUTION FOR INJECTION | |||||
125455392 | 12545539 | 2 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | N | UNKNOWN | 0 | 45 | MG | SOLUTION FOR INJECTION | |||||
125455392 | 12545539 | 3 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | N | UNKNOWN | 0 | 45 | MG | SOLUTION FOR INJECTION | |||||
125455392 | 12545539 | 4 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | N | UNKNOWN | 0 | 45 | MG | SOLUTION FOR INJECTION | |||||
125455392 | 12545539 | 5 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | N | UNKNOWN | 0 | 45 | MG | SOLUTION FOR INJECTION | |||||
125455392 | 12545539 | 6 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | N | UNKNOWN | 0 | 45 | MG | SOLUTION FOR INJECTION | |||||
125455392 | 12545539 | 7 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | N | UNKNOWN | 0 | 45 | MG | SOLUTION FOR INJECTION | |||||
125455392 | 12545539 | 8 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | N | UNKNOWN | 0 | 45 | MG | SOLUTION FOR INJECTION | |||||
125455392 | 12545539 | 9 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | N | UNKNOWN | 0 | 45 | MG | SOLUTION FOR INJECTION | |||||
125455392 | 12545539 | 10 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | N | UNKNOWN | 0 | 45 | MG | SOLUTION FOR INJECTION | |||||
125455392 | 12545539 | 11 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | N | UNKNOWN | 125261 | 45 | MG | SOLUTION FOR INJECTION | |||||
125455392 | 12545539 | 12 | C | CYCLOSPORIN | CYCLOSPORINE | 1 | Oral | BID-TID/DAY | 0 | 100 | MG | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125455392 | 12545539 | 1 | Psoriasis |
125455392 | 12545539 | 2 | Psoriasis |
125455392 | 12545539 | 3 | Psoriasis |
125455392 | 12545539 | 4 | Psoriasis |
125455392 | 12545539 | 5 | Psoriasis |
125455392 | 12545539 | 6 | Psoriasis |
125455392 | 12545539 | 7 | Psoriasis |
125455392 | 12545539 | 8 | Psoriasis |
125455392 | 12545539 | 9 | Psoriasis |
125455392 | 12545539 | 10 | Psoriasis |
125455392 | 12545539 | 11 | Psoriasis |
125455392 | 12545539 | 12 | Psoriasis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125455392 | 12545539 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125455392 | 12545539 | Herpes zoster |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125455392 | 12545539 | 1 | 20131002 | 0 | ||
125455392 | 12545539 | 2 | 20131030 | 0 | ||
125455392 | 12545539 | 3 | 20140115 | 0 | ||
125455392 | 12545539 | 4 | 20140416 | 0 | ||
125455392 | 12545539 | 5 | 20140716 | 0 | ||
125455392 | 12545539 | 6 | 20141202 | 0 | ||
125455392 | 12545539 | 7 | 20150217 | 0 | ||
125455392 | 12545539 | 8 | 20150603 | 0 | ||
125455392 | 12545539 | 9 | 20150826 | 0 | ||
125455392 | 12545539 | 10 | 20160113 | 0 | ||
125455392 | 12545539 | 11 | 20160406 | 0 | ||
125455392 | 12545539 | 12 | 20131002 | 0 |